Hostname: page-component-7b7567c8c-kwt9d Total loading time: 0 Render date: 2026-11-12T16:49:45.704Z Has data issue: false hasContentIssue false

A Taenia crassiceps metacestode factor enhances ovarian follicle atresia and oocyte degeneration in female mice

Published online by Cambridge University Press:  20 August 2013

S. Solano
Affiliation:
Departamento de Microbiología y Parasitología, Facultad de Medicina, Universidad Nacional Autónoma de México, 04510México, D.F., México
N. Zepeda
Affiliation:
Departamento de Bioquímica y Biología Estructural, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, 04510México D.F., México
N. Copitin
Affiliation:
Departamento de Bioquímica y Biología Estructural, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, 04510México D.F., México
A.M. Fernandez
Affiliation:
Departamento de Microbiología y Parasitología, Facultad de Medicina, Universidad Nacional Autónoma de México, 04510México, D.F., México
P. Tato
Affiliation:
Departamento de Microbiología y Parasitología, Facultad de Medicina, Universidad Nacional Autónoma de México, 04510México, D.F., México
J.L. Molinari*
Affiliation:
Departamento de Bioquímica y Biología Estructural, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, 04510México D.F., México
*
*Fax: +52 55–56-22–56-30 E-mail: jmolinar@ifc.unam.mx
Rights & Permissions [Opens in a new window]

Abstract

The histopathological effects of Taenia crassiceps infection or T. crassiceps metacestode factor inoculation on the mouse ovary were determined using six female mice in three groups: infected mice, mice inoculated with the metacestode factor and control mice. The control group was subcutaneously inoculated with healthy peritoneal fluid. The infected group was intraperitoneally inoculated with 40 T. crassiceps metacestodes, and the metacestode factor group was subcutaneously inoculated with T. crassiceps metacestode factor (MF). Light and electron microscopy and TUNEL (terminal deoxynucleotidyl transferase (TdT)-mediated dUTP nick end labelling) assays revealed a significant increase in ovarian follicular atresia (predominantly in antral/preovulatory stages of development), oocyte degeneration (P< 0.05), and a decrease in the amount of corpus luteum in follicles of mice infected and inoculated with MF compared with the control group. Significant abnormalities of the granulosa cells and oocytes of the primordial, primary and secondary ovarian follicles occurred in both treated mouse groups (P< 0.05) compared with no degeneration in the control group. These pathological changes in female mice either infected with T. crassiceps metacestodes or inoculated with T. crassiceps MF may have consequences for ovulation and fertility.

Information

Type
Research Papers
Copyright
Copyright © Cambridge University Press 2013 
Figure 0

Fig. 1Elution profiles of the peritoneal fluids from mice infected with Taenia crassiceps (♦) and control mice (△) using a Sephadex G-50 column; molecular weight standards are 1 = 105.92 kDa, 2 = 36.84 kDa, 3 = 9.2 kDa, and 4 = 1.3 kDa.

Figure 1

Fig. 2The mean number ( ±  SD) of atretic (grey bars) and non-atretic follicles (white bars): (A) total atretic and non-atretic follicles; (B) antral atretic and non-atretic follicles. (C) The degenerated (grey bars) and non-degenerated oocytes (white bars) in the ovaries of mice infected with Taenia crassiceps, metacestode factor-treated mice (MF) and controls. P< 0.05(*), P< 0.01(**) and P< 0.001(***).

Figure 2

Fig. 3Apoptosis in ovaries from control (A), Taenia crassiceps-infected (B), and MF-treated mice (C, D–G) to show (A) an atretic anthral follicle and some ovary peripheral fluorescent cells; (B) and (C) fluorescent (TUNEL-positive) granulosa cells in primary and secondary follicles (arrows); (D–G) fluorescent granulosa cells, a fragmented oocyte nucleolus (arrowhead) and oocyte nucleoli (arrows).

Figure 3

Fig. 4Alterations to the ovary of Taenia crassiceps-infected mice (A, B, C) and MF-treated mice (D, E, F): in (A) intact secondary follicle, oocyte (Oo), zona pellucida (ZP), and granulosa cells (G), 600 × ; in (B) degenerated primordial follicle, oocyte nucleus (N), oocyte cytoplasm (C), nucleolus (*), theca cell (Tc) 600 × ; in (C) degenerated mitochondria (M) in the oocyte cytoplasm, an empty giant mitochondrion (gM), separation of the bilayer of the nuclear membrane (Nm), and a portion of the nucleus (N) (magnification of a section of (B)) 4000 × ; in (D) a degenerated primary follicle, a macrophage surrounding a granulosa cell (white arrows), enlarged and empty mitochondria (black arrow), hypervacuolated oocyte cytoplasm, giant mitochondrion in a granulosa cell (gM), degenerated engulfed granulosa cell (G), degenerated theca cell (T), 800 × ; in (E) an oocyte nucleus, precipitated chromatin (CH), 800 × ; in (F) a degenerated secondary follicle, degenerated granulosa cells (G, one is pyknotic and the other is an empty cytoplasmic membrane) and a degenerated theca cell (T), 600 × .

Figure 4

Fig. 5Degeneration of ovaries from MF-treated (A, B, C, F), control (D) and Taenia crassiceps-infected mice (E) to show: (A–C) degenerated primary follicles, degenerated oocyte cytoplasm (C), oocyte membrane remnants (Mr), microtubules (Mi), granulosa cell cytoplasm (GC), granulosa cell (G), and microtubule stumps (Mis), 3000 × , 600 ×  and 1500 × , respectively; (D) a control intact follicle zona pellucida (ZP), 800 × ; (E) an atretic follicle with a macrophage (M) among several morphologically altered granulosa cells (G) and some apoptotic bodies (ab) inside macrophage cytoplasm, 800 × ; (F) an atretic follicle with several macrophages (M and arrows) interspersed among altered granulosa cells (G), 800 × .